Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inbox Gmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscription Click this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Additional Reading from MarketBeat 3 Cash-Flow Machines Investors May Want Heading Into 2026Author: Nathan Reiff. Published: 1/2/2026. 
Key Points - Strong cash flow is a crucial indicator of a company's healthy operations, enabling it to pay down debt, enhance shareholder value, and sustain long-term growth.
- Semiconductor firm Qualcomm stands out for its 15% year-over-year cash flow growth in the last quarter.
- Gilead Sciences and Exxon Mobil both have healthy cash flows, allowing for attractive dividend distributions.
Among the many financial metrics investors consider when deciding whether to buy a company's shares, cash flow is one of the most important. Operating cash flow reflects how a firm performs day to day and shows its ability to generate cash from sales and other activities to pay salaries, taxes, and operating expenses. Free cash flow, by contrast, is what remains after operating expenses and capital expenditures (CapEx) are deducted—discretionary cash available for expansion, shareholder returns, mergers and acquisitions, and more. Cash flow keeps a company operating, supports growth and expansion, and reduces the risk of bankruptcy. Many investors also consider it harder to manipulate in financial reports than net income, which can be affected by accounting choices. Heading into the new year, investors seeking strong cash-generating companies might start with the firms below. Record Free Cash Flow for a Growing Semiconductor Firm Free book reveals best crypto play for right now
The smart money sees something most investors don't. A potential rally setting up… and now could be the perfect time to get positioned. Get your FREE copy of this must-read book. Qualcomm Inc. (NASDAQ: QCOM) is a major supplier of semiconductors for phones, vehicles, and various smart devices. Shares showed steady momentum in the last two-thirds of 2025, rising from April through year-end; however, Qualcomm's rally still falls short of the astronomical valuations seen for some semiconductor rivals (per our analysis). For investors focused on cash generation, Qualcomm stands out after reporting $12.8 billion in free cash flow in the most recently reported quarter, up 15% year-over-year (YOY) and a quarterly record for the company. Operating cash flow rose as well, driven by strong sales growth in its handset and automotive divisions. Despite substantial capital spending, Qualcomm ended the quarter with roughly $7.8 billion in cash—largely unchanged YOY—indicating a solid financial position heading into the next quarter. Qualcomm's strong cash flow should support its expansion into high-demand data centers in 2026 while funding shareholder returns; the company's dividend yield is 2.08%. High Margins and Growing Sales Drive Continued Cash Flow Success Biopharma giant Gilead Sciences Inc. (NASDAQ: GILD), known for antiviral therapies for HIV, hepatitis and other conditions, benefits from rising sales and healthy margins. In the latest quarter, its HIV medication Descovy saw sales surge 20% YOY. Gilead is not dependent on a single product, with a broad portfolio that spans liver disease, oncology and more. Free cash flow in the quarter was nearly $4 billion, alongside operating cash flow of $4.1 billion. Cash flow is particularly important in biopharma because the industry requires large, ongoing R&D investment. Gilead is well positioned to continue developing its pipeline thanks to solid cash reserves and continued cash generation. Having cash on hand also enables the company to pay an attractive dividend relative to many healthcare peers: a dividend yield of 2.57% and a payout ratio just under 49%. Shares of GILD climbed by more than a third in 2025, and analysts still see room for further growth in the new year. Huge Oil and Gas Operation Still Maintains Strong Cash Flow The second-largest oil and gas company globally by market capitalization, Exxon Mobil Corp. (NYSE: XOM) is valued at more than half a trillion dollars and generates cash flow consistent with its large upstream and refining operations. Operating cash flow was $14.8 billion in the latest quarter, and free cash flow totaled $6.3 billion despite fairly high CapEx. That level of capital spending is typical for the capital-intensive oil and gas industry, but Exxon maintains healthy liquidity and cash flow. Strong cash generation supports Exxon's operations and potential expansion, and it underpins the company's long-standing commitment to shareholder returns—a dividend yield of 3.42% and more than four decades of consecutive increases.
| 
Post a Comment
Post a Comment